These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 17462553
1. Effect of a sardine supplement on C-reactive protein in patients receiving hemodialysis. Moreira AC, Gaspar A, Serra MA, Simões J, Lopes da Cruz J, Amaral TF. J Ren Nutr; 2007 May; 17(3):205-13. PubMed ID: 17462553 [Abstract] [Full Text] [Related]
2. The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure. Madsen T, Schmidt EB, Christensen JH. J Ren Nutr; 2007 Jul; 17(4):258-63. PubMed ID: 17586424 [Abstract] [Full Text] [Related]
3. The effects of zinc supplementation on serum zinc and cholesterol concentrations in hemodialysis patients. Chevalier CA, Liepa G, Murphy MD, Suneson J, Vanbeber AD, Gorman MA, Cochran C. J Ren Nutr; 2002 Jul; 12(3):183-9. PubMed ID: 12105816 [Abstract] [Full Text] [Related]
4. Effects of unsaturated fat dietary supplements on blood lipids, and on markers of malnutrition and inflammation in hemodialysis patients. Ewers B, Riserus U, Marckmann P. J Ren Nutr; 2009 Sep; 19(5):401-11. PubMed ID: 19541503 [Abstract] [Full Text] [Related]
5. Effect of an increase in C-reactive protein level during a hemodialysis session on mortality. Korevaar JC, van Manen JG, Dekker FW, de Waart DR, Boeschoten EW, Krediet RT, NECOSAD study group. J Am Soc Nephrol; 2004 Nov; 15(11):2916-22. PubMed ID: 15504945 [Abstract] [Full Text] [Related]
6. Supplementation with n-3 and n-6 polyunsaturated fatty acids: effects on lipoxygenase activity and clinical symptoms of pruritus in hemodialysis patients. Begum R, Belury MA, Burgess JR, Peck LW. J Ren Nutr; 2004 Oct; 14(4):233-41. PubMed ID: 15483784 [Abstract] [Full Text] [Related]
8. Effect of intradialytic intravenous administration of omega-3 fatty acids on nutritional status and inflammatory response in hemodialysis patients: a pilot study. Szklarek-Kubicka M, Fijałkowska-Morawska J, Zaremba-Drobnik D, Uciński A, Czekalski S, Nowicki M. J Ren Nutr; 2009 Nov; 19(6):487-93. PubMed ID: 19616450 [Abstract] [Full Text] [Related]
9. The effect of dietary n-3 fatty acids on serum concentrations of C-reactive protein: a dose-response study. Madsen T, Christensen JH, Blom M, Schmidt EB. Br J Nutr; 2003 Apr; 89(4):517-22. PubMed ID: 12654170 [Abstract] [Full Text] [Related]
10. Circulating levels of adhesion molecules in chronic kidney disease correlate with the stage of renal disease and with C-reactive protein. Vaccaro F, Mulè G, Cottone S, Soresi M, Giannitrapani L, Vadalà A, Sparacino V, Calabrese S, Picone FP, Montalto G, Cerasola G. Arch Med Res; 2007 Jul; 38(5):534-8. PubMed ID: 17560459 [Abstract] [Full Text] [Related]
11. C-reactive protein in patients on chronic hemodialysis with different techniques and different membranes. Panichi V, Rizza GM, Taccola D, Paoletti S, Mantuano E, Migliori M, Frangioni S, Filippi C, Carpi A. Biomed Pharmacother; 2006 Jan; 60(1):14-7. PubMed ID: 16330177 [Abstract] [Full Text] [Related]
12. The effect of low dose omega-3 on plasma lipids in hemodialysis patients. Taziki O, Lessan-Pezeshki M, Akha O, Vasheghani F. Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):571-6. PubMed ID: 17951945 [Abstract] [Full Text] [Related]
13. Omega-3 fatty acids supplementation does not affect serum lipids in chronic hemodialysis patients. Poulia KA, Panagiotakos DB, Tourlede E, Rezou A, Stamatiadis D, Boletis J, Zampelas A. J Ren Nutr; 2011 Nov; 21(6):479-84. PubMed ID: 21439849 [Abstract] [Full Text] [Related]
14. Effects of omega-3 fatty acid supplementation on lipid levels in endstage renal disease patients. Bowden RG, Jitomir J, Wilson RL, Gentile M. J Ren Nutr; 2009 Jul; 19(4):259-66. PubMed ID: 19539180 [Abstract] [Full Text] [Related]
15. Effects of zinc supplementation on serum zinc and C-reactive protein concentrations in hemodialysis patients. Rashidi AA, Salehi M, Piroozmand A, Sagheb MM. J Ren Nutr; 2009 Nov; 19(6):475-8. PubMed ID: 19541504 [Abstract] [Full Text] [Related]
20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L. Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [Abstract] [Full Text] [Related] Page: [Next] [New Search]